Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
levetiracetam | antiseizure medicine measurable in serum or plasma under an appropriate assay | The levetiracetam concentration was collected at a documented interval after the dose. | Objective | Drug levels - named analytes and exposure reports |
lingering | continues after other symptoms improve | Describes a lingering cough after the sore throat resolved. | Subjective | Sequence, exposures and use of medicines |
lithium | mood stabilizer measured with a timed blood concentration | The lithium level is documented with the evening dose and morning draw times. | Objective | Drug levels - named analytes and exposure reports |
loss of response | previously documented benefit has diminished or disappeared | The loss of response was assessed after verifying continued exposure. | Assessment | Precision in clinical interpretation and documentation |
lupus anticoagulant assay | phospholipid-dependent testing for a circulating inhibitor | The lupus anticoagulant assay was reviewed with the current anticoagulant exposure. | Objective | Coagulation, antibodies and hemostasis studies |
matrix effect | influence of other components of the sample on analytical response | The laboratory considered a matrix effect when the results differed by method. | Assessment | Drug concentrations, exposure and assay interpretation |
matrix mismatch | specimen type differs from that assumed by the comparator | A matrix mismatch limits comparison of this plasma result with the whole-blood target. | Assessment | Drug concentrations, exposure and assay interpretation |
maximal | at its greatest intensity | Reports that the discomfort was maximal within ten minutes of onset. | Subjective | Sequence, exposures and use of medicines |
medication rationing | taking less medicine than prescribed to extend the supply | The patient reports medication rationing in the week before the refill. | Subjective | Activities, exposure and recovery history |
method comparison | assessment of how results differ between analytical techniques | The method comparison used paired specimens tested on both platforms. | Assessment | Drug concentrations, exposure and assay interpretation |
methotrexate | antimetabolite with protocol-timed levels in high-dose treatment | The methotrexate result is identified by hours from the protocol-defined infusion start. | Objective | Drug levels - named analytes and exposure reports |
midcycle | in the middle portion of the menstrual cycle | Reports intermittent midcycle spotting. | Subjective | Sequence, exposures and use of medicines |
| scheduled dose or event did not occur | Reports two missed evening doses during the trip. | Subjective | Sequence, exposures and use of medicines | |
missed-dose trough | predose result preceded by a missed scheduled dose | Missed-dose trough was annotated with the missing administration. | Assessment | Medication response, exposure and reconciliation |
model misspecification | model structure does not adequately describe the observed data | The mismatch between several timed samples raises concern for model misspecification. | Assessment | Drug concentrations, exposure and assay interpretation |
modifiable | can potentially be changed | Tobacco exposure is a modifiable cardiovascular risk factor. | Assessment | Risk, function and outcomes |
modified duties | work tasks altered to accommodate a functional limitation | The patient reports modified duties that avoid overhead lifting. | Subjective | Activities, exposure and recovery history |
morning cortisol | cortisol concentration from a sample collected in the morning | Morning cortisol was documented with the exact clock time and steroid exposure. | Objective | Glucose monitoring, endocrine testing and urine studies |
mottled | patches of uneven color | The fingertips appear mottled after cold exposure. | Objective | Skin morphology and distribution |
myelosuppression | reduction in bone marrow blood cell production | The hematologist considers treatment-related myelosuppression in the differential. | Assessment | Medication exposure, response and adverse-effect reasoning |
myopathy | muscle disease producing relevant symptoms or findings | The proximal weakness prompted assessment for a possible medication-related myopathy. | Assessment | Medication exposure, response and adverse-effect reasoning |
N-acetylprocainamide | active procainamide metabolite also called NAPA | The laboratory reports N-acetylprocainamide on a separate line from the parent drug. | Objective | Drug levels - named analytes and exposure reports |
nephrotoxic | potentially injurious to the kidneys | The medication review identifies a possible nephrotoxic exposure. | Assessment | Mechanisms and localization |
nephrotoxicity | harmful effect on the kidneys | The team considered possible nephrotoxicity in the context of other exposures. | Assessment | Medication exposure, response and adverse-effect reasoning |
neurotoxicity | harmful effect on the nervous system | The new tremor prompted assessment for possible medication-related neurotoxicity. | Assessment | Medication exposure, response and adverse-effect reasoning |